Intellia Therapeutics, Inc. (NTLA): Price and Financial Metrics

Intellia Therapeutics, Inc. (NTLA): $12.06

0.23 (+1.94%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add NTLA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#270 of 307

in industry

NTLA Price/Volume Stats

Current price $12.06 52-week high $27.42
Prev. close $11.83 52-week low $5.90
Day low $11.86 Volume 3,837,700
Day high $12.55 Avg. volume 3,943,601
50-day MA $9.34 Dividend yield N/A
200-day MA $0.00 Market Cap 1.25B

NTLA Stock Price Chart Interactive Chart >


Intellia Therapeutics, Inc. (NTLA) Company Bio


Intellia Therapeutics a gene editing company, develops therapeutics utilizing a biological tool known as the CRISPR/Cas9 system. The company develops in vivo programs focused on liver diseases, including transthyretin amyloidosis, alpha-1 antitrypsin deficiency, hepatitis B virus, and inborn errors of metabolism; and ex vivo applications of the technology in chimeric antigen receptor T cell and hematopoietic stem cell product candidates. The company was founded in 2014 and is headquartered in Cambridge, Massachusetts.


NTLA Latest News Stream


Event/Time News Detail
Loading, please wait...

NTLA Latest Social Stream


Loading social stream, please wait...

View Full NTLA Social Stream

NTLA Price Returns

1-mo 31.09%
3-mo 52.27%
6-mo 21.33%
1-year -51.91%
3-year -82.32%
5-year -42.46%
YTD 3.43%
2024 -61.76%
2023 -12.61%
2022 -70.49%
2021 117.35%
2020 270.82%

Continue Researching NTLA

Want to see what other sources are saying about Intellia Therapeutics Inc's financials and stock price? Try the links below:

Intellia Therapeutics Inc (NTLA) Stock Price | Nasdaq
Intellia Therapeutics Inc (NTLA) Stock Quote, History and News - Yahoo Finance
Intellia Therapeutics Inc (NTLA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!